Welcome to the Leukemia & Lymphoma Learning Center, an educational resource for professionals interested in CME/CE activities focusing on leukemia and lymphoma. Here you will find multiple programs designed to address barriers to care and management and treatment of these critical diseases. Each initiative has been created to engage hematologists, oncologists, and other learners across multiple learning formats. This resource will encompass all areas of hematologic malignancies, each with its own learning track and associated educational activities.
This patient-to-patient video serves as an educational resource for both patients and clinicians. It features a patient with chronic lymphocytic leukemia and a physician who together overcame the challenges they faced, from initial diagnosis to achieving disease remission in this patient. This video highlights the importance of shared decision-making and personalizing therapy.
This patient education video serves as an educational resource for clinicians and patients. The video describes the patient experience and portrays the interaction between the patient and the patient's clinician, to convey the value of shared decision-making in the patient experience.
Our faculty experts will provide answers periodically to common and perplexing questions.Click here to submit your question.
Question: Why does early lymphocytosis occur after treatment with the class of agents known as BCR antagonists?
Answer: Studies suggest that this transient increase in circulating lymphocytes occurs because BCR signaling promotes the movement of B cells to the bone marrow and lymph nodes. Inhibiting this trafficking releases the cells back into the circulation.
*Disclaimer: Non-accredited resources supported by Haymarket Medical Education
Select activities provided by
In partnership with
Select activities are supported by educational grants from
Gilead Sciences, Inc.
Seattle Genetics, Inc.